INOVIQ's recent validation study of its EXO-OC test revealed it can detect stage one ovarian cancer with 96% specificity and more than 90% sensitivity, a promising advance for early detection.
The company's breast cancer screen test has also demonstrated superior accuracy over current tests.
Copyright 2024 – Finance News Network
Source: Finance News Network
23 Sep 2024 - Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt discusses the company's latest results in head and neck cancer.
Read More11 Mar 2021 - Rural Funds Group Limited (ASX:RFF) General Manager - Investor Relations and Marketing, James Powell, presents on the group's HY21 results.
Read More31 07 2024 - Amy Dickinson - Event Manager - Equity Events is a Brisbane based company which specialises in organising investment events for the mining, energy, exploration and industrial sectors.
Read More23 Sep 2019 - Lake Resources Limited (ASX:LKE) Managing Director, Steve Prominitz provides an update on progress across the company's project portfolio.
Read More18 Sep 2023 - NOVONIX (ASX:NVX) achieved successful production with its Generation 3 Furnaces, meeting design goals for throughput, cost, and sustainability.
Read More21 Jul 2021 - icetana (ASX:ICE) CEO and Managing Director Matt Macfarlane provides an update for the June quarter 2021.
Read More25 May 2023 - Mad Paws Limited (ASX:MPA) Managing Director Justus Hammer discusses the company's business model, effects of the macro environment, competition and differentiation, the company's online marketplace and ecosystem, M&A opportunities, the integration of Pet Chemist and outlook.
Read More08 Jun 2021 - MLC Asset Management Senior Economist Bob Cunneen discusses factors behind gains in the global economy and the Australian market over May.
Read More30 Mar 2022 - Immutep Limited (ASX:IMM) Executive Director and CEO Marc Voigt discusses the company's LAG-3-related therapies, outlining future plans and expected data readouts for Immutep's lead drug, eftilagimod alpha.
Read More21 Mar 2021 - Elixinol Global (ASX:EXL) CEO, Oliver Horn talks about its proposed acquisition of CannaCare Health GmbH (CannaCare) one of Germany’s leading CBD (Cannabidiol) brands following the down scheduling of CBD in Europe late last year in what the Company sees as highly strategic opportunity and important pathway to profitability.
Read More
